Neurogene Inc.

IPO

Neurogene - Developing Purpose-built Genetic Medicines

Neurogene Inc. is a biotech company in New York, United States, founded in 2018. It has raised $183.5M across 2 rounds, most recently a $115.0M Series B in December 2020.

Headquarters
New York, New York
Employees
51–200
Founded
2018
Business Model
B2B
Total Funding
$183.5M
Last Round
$115.0M Series BDec 2020
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 13 investors for this company. to use credits for reveals, or explore the API.

About

Neurogene is a clinical-stage gene therapy company advancing genetic medicines for rare neurological diseases, with its lead program NGN-401 targeting Rett syndrome using a proprietary EXACT technology platform designed to overcome dosage-sensitivity limitations of conventional gene therapy approaches.

Funding & Exit History

Data from Indexed.vcUpdated
Secondary MarketSecondary MarketNov 2024

3 more events

  • IPO202311 investors
  • Series B20209 investors
  • Series A20194 investors

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Marketing & SEO ×2
  • Backend ×1
  • Cloud/Infrastructure ×1

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurogene Inc. on Indexed.vc
<a href="https://indexed.vc/companies/neurogene-inc"><img src="https://indexed.vc/api/badge/company/neurogene-inc" alt="Neurogene Inc. on Indexed.vc" width="260" height="76" /></a>